Biogen, Inc. (BIIB)
169.31
-8.99
(-5.04%)
USD |
NASDAQ |
Jan 14, 16:00
168.98
-0.33
(-0.19%)
After-Hours: 20:00
Biogen Profit Margin (Quarterly): 19.00% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 31.72% |
| Stoke Therapeutics, Inc. | -360.7% |
| AbbVie, Inc. | 1.13% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Insmed, Inc. | -260.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 9.36% |
| Return on Assets | 5.67% |
| Return on Invested Capital | 6.75% |
| Gross Profit Margin (Quarterly) | 64.29% |
| Operating Margin (Quarterly) | 25.00% |
| Return on Net Operating Assets | 6.75% |